Alivus Life Sciences Limited (NSE:ALIVUS)
India · Delayed Price · Currency is INR 919.80
-2.85 (-0.31%)
At close: Feb 13, 2026
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 112.89 billion as of February 13, 2026. Its market cap has decreased by -23.06% in one year.
Market Cap
112.89B
Enterprise Value
106.97B
Revenue
25.12B
Ranking
n/a
PE Ratio
20.80
Stock Price
919.80
Market Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 112.89B, an increase of 23.10%. That is a compound annual growth rate of 4.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 112.89B | 0.39% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | 91.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 276.42B |
| Wockhardt | 224.71B |
| Piramal Pharma | 216.85B |
| Eris Lifesciences | 209.23B |
| Alembic Pharmaceuticals | 155.27B |
| NATCO Pharma | 150.43B |
| Cohance Lifesciences | 134.19B |
| Strides Pharma Science | 79.80B |